tbuckley/cabot-search huggingface dataset:
Firing probability and mean firing rates of human muscle vasoconstrictor neurones are elevated during chronic asphyxia
Authors: Cynthia Ashley, Danielle Burton, Yrsa B Sverrisdottir, Mikael Sander, David McKenzie, Vaughan G Macefield
Journal: European Respiratory Journal (2010)

Elevated muscle sympathetic nerve activity (MSNA) features in many cardiovascular diseases, but how this sympathoexcitation is brought about differs across pathologies. Unitary recordings from post-ganglionic muscle vasoconstrictor neurones in human subjects have shown that the augmented MSNA in the obstructive sleep apnoea syndrome (OSAS) is associated with an increase in firing probability and mean firing rate, and an increase in multiple within-burst firing. Here we characterize the firing properties of muscle vasoconstrictor neurones in patients with chronic obstructive pulmonary disease (COPD), who are chronically asphyxic. We tested the hypothesis that this elevated chemical drive would shift the firing pattern from that seen in healthy subjects to that seen in OSAS. The mean firing probability (52%) and mean firing rate (0.92 Hz) of 17 muscle vasoconstrictor neurones recorded in COPD were comparable to those previously recorded in OSAS (51% and 0.96 Hz), but significantly higher than those recorded in a group of healthy subjects with high levels of resting MSNA (35% and 0.33 Hz). In COPD single neurones fired once in 63% of cardiac intervals, comparable to OSAS (59%), but significantly lower than in the healthy group (78%). Conversely, single neurones fired twice in 25% of cardiac intervals, similar to OSAS (27%), but significantly higher than in the healthy group (18%). We conclude that the chronic asphyxia associated with COPD results in an increase in the firing probability and mean firing frequency of muscle vasoconstrictor neurones and causes a shift towards multiple firing, reflecting an increase in central muscle vasoconstrictor drive.
Low Incidence of Complete Remission but Comparable Event-Free Survival(EFS) and Overall Survival (OS) with a History of Prior Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Myeloma (SMM) among Patients Receiving Total Therapy 2 (TT 2).
Authors: Athanasios Fassas, Bart Barlogie, Erik Rasmussen, Teresa Milner, Julian Terry, Maurizio Zangari, Giampaolo Talamo, Choon-Kee Lee, Raymond Thertulien, John Crowley, Guido Tricot
Journal: Blood (2004)
Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.
Authors: Cynthia Toze, Chinmay B. Dalal, Tanya L. Gillan, Thomas J. Nevill, Michael J. Barnett, Stephen H. Nantel, Donna E. Hogge, Donna L. Forrest, Heather Sutherland, Kevin Song, Raewyn Broady, Maryse Power, Sujaatha Narayanan, Clayton A. Smith, John Shepherd
Journal: Blood (2010)
Lack of Response of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) to Decitabine After Failure of Azacitidine
Authors: Bhavana Bhatnagar, Dan P. Zandberg, Emily J. Vannorsdall, Alison P. Duffy, Michael L. Tidwell, Yi Ning, Qing Chen, Maria R. Baer
Journal: Blood (2012)
The Impact of Aging of Hematopoietic Stem and Progenitor Cells (HSPCs) in Non-Human Primates As Interrogated By Genetic Barcode Clonal Tracking
Authors: Kyung-Rok Yu, Chuanfeng Wu, Diego Espinoza, Idalia Yabe, Sandhya R. Panch, So Gun Hong, Samson Jonathan Koelle, Rong Lu, Aylin Bonifacino, Alan Krouse, Mark Metzger, Robert Donahue, Cynthia E. Dunbar
Journal: Blood (2015)
Outcomes by Cytogenetic and Molecular Response at 12 and 18 Months of Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) in the IRIS Trial.
Authors: Michele Baccarani, Francois Guilhot, Richard A. Larson, Stephen G. O’Brien, Brian J. Druker
Journal: Blood (2006)
Dynamic Increase in JAK2V617F Allele Burden Is a Predictive Parameter for the Transformation into Myelofibrosis from Polycythemia Vera and Essential Thrombocytosis
Authors: Shuichi Shirane, Marito Araki, Soji Morishita, Yumi Hironaka, Masaaki Noguchi, Michiaki Koike, Takao Hirano, Akimichi Ohsaka, Norio Komatsu
Journal: Blood (2014)
Predicting Disease Progression to Multiple Myeloma (MM) From MGUS/SMM In SWOG-0120 Observational Trial
Authors: Madhav Dhodapkar, John Shaughnessy, Antje Hoering, Bijay Nair, Vanessa Bolejack, Frits van Rhee, John Crowley, Bart Barlogie
Journal: Blood (2010)
A Novel Activating Mutation Of CXCR4 Plays a Crucial Role In Waldenstrom Macroglobulinemia Biology
Authors: Aldo M Roccaro, Antonio Sacco, Cristina Jimenez, Patricia Maiso, Michele Moschetta, Yuji Mishima, Michelle R. Kuhne, Pina M. Cardarelli, San Miguel Jesus F, Ramon Garcia-Sanz, Irene M. Ghobrial
Journal: Blood (2013)
CD19 Expression in t(8;21)-Negative Acute Myeloid Leukemia Is Not Restricted to Cytogenetically Aberrant Populations.
Authors: Jawad Francis, Avinash Dharmadhikari, Sheila N.J. Sait, George Deeb, Paul K. Wallace, James E. Thompson, Eunice S. Wang, Meir Wetzler
Journal: Blood (2009)
Antitumor activity of TAK-788 in NSCLC With EGFR exon 20 insertions
Authors: Pasi A. Jänne, Joel W. Neal, D.R. Camidge, Alexander Spira, Zofia Piotrowska, Leora Horn, Daniel B. Costa, Anne Tsao, Jyoti Patel, Shirish Gadgeel, Lyudmila Bazhenova, Viola W Zhu, Howard West, Sylvie Vincent, Jian Zhu, Shuanglian Li, Gregory J. Riely
Journal: Annals of Oncology (2019)
Induction Therapy Followed by Allogeneic Stem Cell Transplant for MPN Blast Phase: Outcomes From Mayo Clinic in Arizona
Authors: Chad Cherington, James L. Slack, Jose F. Leis, Roberta H. Adams, Craig B. Reeder, Joseph R. Mikhael, John Camoriano, Pierre Noel, Raoul Tibes, Jeffrey A. Betcher, Mary E Peterson, Meagan S. Higgins, Ginger Gillette-Kent, Lisa D. Tremblay, Jane J Olsen, Ruben A. Mesa
Journal: Blood (2011)
A pivotal role of team medicine for recurrent ovarian cancer patient affected by Clostrioides difficile enterocolitis
Authors: Kenzo Sonoda, Rie Sugimoto, Yoriko Ando, Seiko Miyamoto, Aya Matsukura, Yuko Hashimoto, Kiyoshi Aiko, Shoji Maenohara, Yui Tomita, Shoko Kitade, Rina Nagayama, Kazuya Ariyoshi, Masao Okadome, Toyomi Ninomiya, Toshiaki Saito
Journal: Annals of Oncology (2019)
A Novel Recombinant Eklf-GATA1 Fusion Protein Reduces Sickling of Erythrocytes Cultured from CD34+ Cells with Sickle Cell Disease
Authors: Jianqiong Zhu, Kyung Chin, Wulin Aerbajinai, Chutima Kumkhaek, Hongzhen Li, Matthew M. Hsieh, Courtney D. Fitzhugh, Griffin P. Rodgers
Journal: Blood (2016)
Itraconazol Inhibits the P-Glycoprotein Pump and Increases Vincristine Induced Toxicity in Patients with Acute Lymphoblastic Leukemia Carrying a Genetic Variant of the MDR1 Gene
Authors: D. Maroeska W.M. te Loo, Melanie Hagleitner, Peter M. Hoogerbrugge, Rosalinde Masareeuw, Marieke Coenen
Journal: Blood (2011)
Towards a Better Understanding of Epidemiology, Survival and Treatment in Myeloproliferative Neoplasms: Results of the European Leukemianet Registry (ERNEST study)
Authors: Tiziano Barbui, Arianna Masciulli, Marco Scarano, Gianni Tognoni, Sara Sisti, Alessandra Di Lelio, Alessandro M. Vannucchi, Mario Cazzola, Alessandro Rambaldi, Konstanze Doehener, Francisco Cervantes, Francesco Passamonti, Andreas Reiter, Steffen Koschmieder, Dietger Niederwieser, Bjorn Andreasson, Peter L. Johansson, Andreas Hochhaus, Claire N. Harrison
Journal: Blood (2014)
Skin Blood Flow Measured By LSCI Demonstrates Treatment Effect of Chronic Transfusion Protocol in Sickle Cell Disease
Authors: Nicolas V Currier, Gersham Dent, Paul S. Swerdlow, Willem Birkhoff, Jacobus Burggraaf, Jaspert de Vries, Jaladhar Neelavalli, Muhammad Shahid, Brijesh K Yadav, William E. Hobbs, Ajay Verma
Journal: Blood (2016)
Dynamic Features Occurring during Multiple Myeloma Course Can Modify the Outcome Predicted at Diagnosis By R-ISS Stage
Authors: Massimo Offidani, Laura Corvatta, Sonia Morè, Valerio Mori, Silvia Gentili, Kimberly Blaine Garvey, Alessandra Bossi, Laura Maracci, Pietro Leoni
Journal: Blood (2016)
Induction of Apoptosis and Autophagy By Nampt Inhibition in Adult T-Cell Leukemia/Lymphoma and Leukemic Cell Lines
Authors: Tomohiro Kozako, Makoto Yoshimitsu, Naomichi Arima, Keisuke Sato, Moe Toyoshima, Shin-ichiro Honda, Shinji Soeda
Journal: Blood (2016)
Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Patients in Early Stage Disease,
Authors: Sonia Fabris, Mirjam Hoxha, Luca Agnelli, Laura Dioni, Valentina Bollati, Gabriella Ciceri, Laura Mosca, Marzia Barbieri, Giovanna Cutrona, Serena Matis, Massimo Gentile, Giorgio Lambertenghi Deliliers, Agostino Cortelezzi, Fortunato Morabito, Manlio Ferrarini, Andrea Baccarelli, Antonino Neri, Pier Alberto Bertazzi
Journal: Blood (2011)
Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses
Authors: Sjoerd T. T. Schetters, Wouter S. P. Jong, Laura J. W. Kruijssen, H. B. van den Berg van Saparoea, Steef Engels, Wendy W. J. Unger, Diane Houben, Joke M. M. den Haan, Joen Luirink, Yvette van Kooyk
Journal: Cellular and Molecular Immunology (2019)
Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma
Authors: Nicolaus Kröger, Heidi Duske, Tatjana Zabelina, Thomas Binder, Boris Fehse, Orhan Sezer, Thomas Stübig, York Hildebrandt, Djordje Atanackovic, Axel R. Zander, Thomas Eiermann
Journal: Blood (2010)
Two Long Non-Coding RNAs Are Sufficient to Classify and Significantly Predict In Vivo Engraftment Potential and LSC Properties of Human Acute Myeloid Leukemia Cells
Authors: Susann Ihme, Hartmut Döhner, Konstanze Döhner, Michaela Feuring-Buske, Christian Buske, Medhanie A. Mulaw
Journal: Blood (2016)
Incidence and Mortality Trends of Cholangiocarcinoma; Are Asian Patients Different From Other Ethnicities?
Authors: Mohamed M. Gad, Anas M. Saad, Muneer J. Al-Husseini, Inas A. Ruhban, Mahmad Wafa Khoudeir, Khalid A. Jazieh, Carlos Roberto Simons-Linares
Journal: Annals of Oncology (2019)
Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma
Authors: Nicolaus Kröger, Tatjana Zabelina, Francis Ayuk, Christine Wolschke, Haefaa Alchalby, Anita Badbaran, Djordje Atanackovic, Georgia Schilling, Orhan Sezer, Ulrike Bacher, Thomas Stübig, Boris Fehse, Axel R. Zander
Journal: Blood (2011)
Durable Remission after Prophylactic Donor Lymphocyte Transfusion Following Allogeneic Stem Cell Transplantation with Reduced Conditioning for High-Risk AML and MDS.
Authors: Michael Schleuning, Christoph Schmid, Georg Ledderose, Johanna Tischer, Meike Humann, Johanna Ullmann, Rainer Schwerdtfeger, Hans-Jochem Kolb
Journal: Blood (2004)
Pediatric Therapy In Adult Acute Lymphoblastic Leukemia: Updated Experience of a Single Centre
Authors: Stefania Paolini, Sarah Parisi, Ilaria Iacobucci, Cristina Papayannidis, Maria Chiara Abbenante, Antonio Curti, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli
Journal: Blood (2010)
The Microenvironmental Stromal Cells Abrogate NF-κb Inhibitor Induced Apoptosis in Chronic Lymphocytic Leumkemia
Authors: Katharina Foerster, Carl Philipp Simon-Gabriel, Dorothee Bleckmann, Marco Benkisser-Petersen, Nicolas Thornton, Rainer Claus, Justus Duyster, Katja Zirlik
Journal: Blood (2016)
A Cost-Benefit Analysis of D-Dimer Measurement by a High Sensitivity Asay, as the First Step to Rule out a Venous Thromboembolism Suspected Episode, Independently of Pretest Clinical Probability.
Authors: Francesc J Casals, Davide Bernaudo, Jaume Villalta, Naila Lozano, Gines Escolar
Journal: Blood (2008)
A Phase 1/2 Study of RAD001, a mTOR Inhibitor, In Patients with Myelofibrosis: Final Results
Authors: Alessandro M. Vannucchi, Paola Guglielmelli, Letizia Lupo, Maria Chiara Finazzi, Lorenzo Tozzi, Flavia Biamonte, Arianna Masciulli, Maria Chiara Susini, Alessandro Pancrazzi, Guido Finazzi, Simona Paratore, Roberto Marchioli, Alberto Bosi, Tiziano Barbui, Alessandro Rambaldi, Giovanni Barosi
Journal: Blood (2010)
SNP-Based Genome-Wide Identification of Hematopoiesis-Restricted Minor Histocompatibility Antigens
Authors: Pleun Hombrink, Sine R Hadrup, Arne Bakker, J.H. Frederik Falkenburg, Peter A. Von Dem Borne, Ton N Schumacher, Mirjam H.M. Heemskerk
Journal: Blood (2008)
Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia
Authors: Xiao J. Yan, Igor Dozmorov, Ivanovic Ivana, Sophia Yancopoulos, Daniel Kalenscher, Erin Boyle, Aarti Damle, Rajendra N Damle, Charles C. Chu, Houman Khalili, Annette Lee, Wentian Li, Peter Gregersen, Cristina Sison, Martin L Lesser, Matthew Kaufman, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Nicholas Chiorazzi
Journal: Blood (2011)
A service improvement project exploring the extent of need for allied health care professionals within neuro-oncology in Velindre Cancer Centre.
Authors: Rachel Evans, Hayley Williams, Lisa Love-Gould, Owen Tilsley, James Powell, Rhian Burke, Najmus Sahar Iqbal, Karen Johnson, Siobhan Pearce, Rhiannon Williams, Elizabeth Halon, Callum Evans
Journal: Neuro-Oncology (2019)

Abstract Given the highly complex and holistic needs of neuro-oncology patients, gold standard guidelines recommend that support is best served by a coordinated multi-disciplinary team (MDT) to provide seamless care from diagnosis to end of life (NICE 2018). Allied Healthcare Professionals (AHPs) including occupational therapy (OT), physiotherapy (PT), speech and language therapy (SLT) and dietitians (DT) are recognised as key professions within the MDT. As there is no designated AHP team at Velindre Cancer Centre, input can be reactive and fragmented with limited opportunity for patient education or service developments. The aim of the project was to scope and evaluate the level of AHP need the neuro-oncology population attending Velindre Cancer Centre. A service improvement grant funded a Band 4 Therapies support worker to conduct the project. The project involved a number of elements including the implementation of a revised neuro-oncology screening tool, strategic effort to improve patient education and self-management and engaging patients and staff to guide future service developments. The mixed methods approach yielded rich quantitative and qualitative data. The results demonstrated that whilst AHP input was beneficial to patient care, significant unmet needs were highlighted and demands for services exceeded the teams’ capacity. Therefore a designated neuro-oncology therapies team should be a central consideration for future care to enable timely, responsive, equitable and seamless MDT working. Greater AHP resource would also enable greater AHP involvement in research and education to revolutionise care in order to fully meet the needs of this vulnerable and complex patient group.
Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Patients with at Least 2 Lines of Prior Therapy and Relapsed or Relapsed and Refractory Multiple Myeloma
Authors: Ajai Chari, Sagar Lonial, Attaya Suvannasankha, Joseph W. Fay, Bertrand Arnulf, Jainulabdeen J. Ifthikharuddin, Xiang Qin, Tara Masterson, Kerri Nottage, Jordan M Schecter, Tahamtan Ahmadi, Brendan Weiss, Amrita Krishnan, Suzanne Lentzsch
Journal: Blood (2015)
Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry
Authors: Christine Teutsch, Menno V Huisman, Gregory Y.H. Lip, Hans-Christoph Diener, Sergio J Dubner, Ma Changsheng, Kenneth J Rothman, Kristina Zint, Amelie Elsaesser, Miney Paquette, Dorothee B Bartels, Jonathan Halperin
Journal: Blood (2016)
Long-Term Follow-up of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Severe Paroxysmal Nocturnal Hemoglobinuria
Authors: Jeremy Pantin, Xin Tian, Nancy Geller, Catalina Ramos, Lisa Cook, Sophia Grasmeder, Philip Scheinberg, Neal S. Young, Sumithira Vasu, Theresa Donohue, Richard Childs
Journal: Blood (2010)
A Wharton's Jelly Mesenchymal Stromal Cell Derived 3D Osteogenic Niche Allows for Cord Blood Stem Cell Attachment
Authors: Omar S. Aljitawi, Peggy Keefe, Lindsey Ott, Dandan Li, Da Zhang, Sunil Abhyankar, Rama Garimella, Joseph McGuirk, Michael Detamore
Journal: Blood (2011)
Use of Palifermin for the Prevention of High-Dose Methotrexate-Induced Oral Mucositis.
Authors: Eva Schmidt, Nils H. Thoennissen, Annika Rudat, Ralf Bieker, Christoph Schliemann, Rolf M. Mesters, Michael Zühlsdorf, Carsten Müller-Tidow, Wolfgang E. Berdel
Journal: Blood (2007)
Final Phase I Results of Perifosine In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed or Refractory Multiple Myeloma (MM)
Authors: Andrzej J Jakubowiak, Paul G Richardson, Todd M Zimmerman, Melissa Alsina, Jonathan L. Kaufman, Malathi Kandarpa, Colleen K. Harvey, Kathleen Colson, Monica Mitchell, Teru Hideshima, Peter Sportelli, Lesa Gardner, Kathy Giusti, Kenneth C. Anderson
Journal: Blood (2010)
Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis
Authors: A. van Elsas, S.F. Zerp, S. van der Flier, M. Kruse-Wolters, A. Vacca, D.J. Ruiter, P.I. Schrier
Journal: Cancer Research (1995)

Determination of the activation state of oncogenes as well as tumor suppressor genes is a main subject of interest in the analysis of the mechanism of tumor initiation. In human melanoma, the c-myc and N-ras oncogenes have been found to be activated in approximately 50% and 15% of the analyzed material, respectively. These studies have mostly been done on fresh tumor material or cell lines. Only in a few cases has an attempt been made to look at tumor heterogeneity or clonality with respect to the activation of oncogenes. We have adjusted the polymerase chain reaction (PCR)/single-stranded conformation polymorphism analysis (SSCP) technique to screen paraffin-embedded melanoma material for the presence of N-ras mutations and found genetic defects at particular progression stages. In one melanoma of the skin, we were able to sublocalize an N-ras mutation in the intraepidermal tumor part, that was absent in the part deeply invading the dermal layer. We conclude that a thorough investigation of N-ras activation in human melanoma should include analysis of histologically different parts of the tumor.
Intense Cytarabine-Based Chemo-Immunotherapy, Central Nervous System (CNS) Prophylaxis and Early High-Dose Chemotherapy and Autologous Stem Cell Support (HDC-ASCS) in First Remission Are Associated with an Improved Clinical Outcome in Double-Hit (DHL)/Triple-Hit (THL) Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: Priyank P. Patel, Pallawi Torka, Vishala T. Neppalli, George Deeb, Sheila N.J. Sait, AnneMarie W. Block, Seema A. Bhat, Myron S. Czuczman, Francisco J. Hernandez-Ilizaliturri
Journal: Blood (2014)
Higher Versus Standard Doses of Recombinant Erythropoietin for the Treatment of Anemia in Patients with Myelodysplastic Syndromes: Results of a Retrospective Survey from the Italian Registry of Myelodisplastic Syndromes (FISM)
Authors: Enrico Balleari, Rosa Filiberti, Chiara Salvetti, Bernardino Allione, Emanuele Angelucci, Tullio Calzamiglia, Marina Cavaliere, Daniela Cilloni, Marino Clavio, Anna Da Col, Paolo Danise, Anna Angela Di Tucci, Dario Ferrero, Carlo Finelli, Daniela Gioia, Roberto M Lemoli, Alessandro Levis, Emanuela Messa, Elisa Masera, Maurizio Miglino, Pellegrino Musto, Esther Natalie Oliva, Antonella Poloni, Marco Scudeletti, Rodolfo Tassara, Valeria Santini
Journal: Blood (2016)
The Cutoff Leukemic Cell Burden to Influence Outcomes of Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia In Hematological Complete Remission.
Authors: Sung-Eun Lee, Hee-Je Kim, Woo-Sung Min, Seung-Ah Yahng, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Chong-Won Park
Journal: Blood (2010)
D-Dimer Levels Among Cancer Patients with Unsuspected Pulmonary Embolism: Clinical Correlates and Relevance
Authors: Sonia Ali, Elizabeth Dilday, Scott Tagawa, Naveed H. Akhtar, Howard A Liebman, Pedram Razavi, Leanne Rochanda, David I Quinn, Kathleen Seaton, Casey L. O'Connell
Journal: Blood (2012)
Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months
Authors: Silvia Mori, Philipp le Coutre, Elisabetta Abruzzese, Bruno Martino, Ester Pungolino, Chiara Elena, Ivana Pierri, Sarit E. Assouline, Anna D'Emilio, Antonella Gozzini, Pilar Giraldo, Fabio Stagno, Alessandra Iurlo, Andrea Aroldi, Michela Luciani, Giulia De Riso, Kim Dong-Wook, Alessandra Pirola, Anna Petroccione, Maria Luisa Bonanomi, Patrizia Crivori, Rocco Piazza, Carlo Gambacorti-Passerini
Journal: Blood (2015)
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone (Pom/dex) Is Highly Effective Therapy in Relapsed Multiple Myeloma
Authors: Martha Q. Lacy, Suzanne R. Hayman, Morie A. Gertz, Jacob B. Allred, Sumithra J. Mandrekar, Angela Dispenzieri, Stephen R. Zeldenrust, Shaji Kumar, Philip R. Greipp, John A. Lust, Stephen J Russell, Francis Buadi, Robert A. Kyle, Peter Leif Bergsagel, Rafael Fonseca, Vivek Roy, Joseph Mikhael, A. Keith Stewart, S. Vincent Rajkumar
Journal: Blood (2008)
Abnormal Mitosis and Genetic Instability Induced by Downregulation of Candidate Myeloid Tumor Suppressor Genes Isolated from the Long Arm of Chromosome 7.
Authors: Hiroya Asou, Hirotaka Matsui, Yuko Ozaki, Toshiyuki Takemura, Akiko Nagamachi, Daisuke Aki, Miho Ohsugi, Toshiya Inaba
Journal: Blood (2006)
Bendamustine Plus Rituximab Followed By Rituximab Maintenance for Patients with Untreated Advanced Follicular Lymphomas. Results from the StiL NHL 7-2008 Trial (MAINTAIN trial) (ClinicalTrials.gov Identifier: NCT00877214)
Authors: Mathias J. Rummel, Andreas Viardot, Richard Greil, Bernd Hertenstein, Christian Lerchenmüller, Arnold Ganser, Manfred Reeb, Ulrich Kaiser, Christina Balser, Georg Maschmeyer, Heinz Dürk, Georg Schliesser, Tobias Gaska, Jan Dürig, Axel C. Matzdorff, Rudolf Weide, Axel Hinke, Wolfgang Blau, Alexander Burchardt, Frank Kauff, Jürgen Barth, Wolfram Brugger
Journal: Blood (2014)
The Roles of Stat3 and ERK in G-CSF Signaling.
Authors: Kenjirou Kamezaki, Kazuya Shimoda, Akihiko Numata, Masumi Yoshie, Masahiro Yamamoto, Kiyoshi Takeda, Tadashi Matsuda, Shizuo Akira, Katsuhiro Ogawa, Mine Harada
Journal: Blood (2004)
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease
Authors: Cristina Skert, Alessandro Turra, Michele Malagola, Simone Perucca, Valeria Cancelli, Rosa Daffini, Rossella Ribolla, Cesare Bergonzi, Carla Filì, Chiara Pagani, Andrea Di Palma, Federica Cattina, Simona Bernardi, Domenico Russo
Journal: Blood (2014)
Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
Authors: Chris Ward, Zelal Jaber Kharaba
Journal: European Respiratory Journal (2019)

<b>Alveolar epithelial A549 cells may not be the best model in asthma studies. Proton pump inhibitor use may associate with a dysregulated aerodigestive microbiome, and in obese severe asthmatics obstructive sleep apnoea may be a relevant comorbidity.</b>http://bit.ly/2kMHj7q
A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy Plus Rituximab Vs. CHOP Chemotherapy Plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphoma
Authors: Oliver W. Press, Joseph M Unger, Lisa M. Rimsza, Jonathan Friedberg, Michael LeBlanc, Myron S. Czuczman, Mark S. Kaminski, Rita M. Braziel, David G. Maloney, Bruce D. Cheson, Thomas P. Miller, Richard I Fisher
Journal: Blood (2011)